Incoming MassBio Chairman Eyes Improving Gender Diversity Across the State’s Life Sciences Industry
David Lucchino, chief executive officer of Frequency Therapeutics, is expected to be named the next chairman of MassBio next month. Source: BioSpace
Aldeyra Therapeutics Inks Collaboration Deal with Johnson & Johnson to Develop Anti-inflammatory …
Aldeyra Therapeutics has signed a collaboration research deal with Janssen Research & Development, a Johnson & Johnson company. Source: BioSpace
DBV Technologies Reports Positive Data from Milk Allergy Trial
French company DBV Technologies is seeing some positive results from its milk allergy treatment. Source: BioSpace
Generation Bio Raises $100 Million Series B to Finance Non-Viral Gene Therapy Program
Cambridge, Massachusetts-based Generation Bio closed on a $100 million Series B financing today. Source: BioSpace
Senti Biosciences Raises $53 Million from Amgen and Others in Series A Financing
Senti Biosciences, based in South San Francisco, has completed a $53 million Series A financing. Source: BioSpace
Eli Lilly’s Verzenio Picks Up Third Approved Indication
Eli Lilly snagged regulatory approval for expanded use of cancer treatment Verzenio. Source: BioSpace
A&Z Pharmaceutical Cited for Calibration and Batch Deficiencies
The FDA issued A&Z Pharmaceutical a Form 483 for deficiencies at its Hauppauge, New York facility that included improper storage conditions, poor calibration practices and failure to review batch failures.…
DOJ Files False Claims Act Complaint Against Compounder
The U.S. Department of Justice filed a complaint against Patient Care America, a Pompano Beach, Florida compounding pharmacy, claiming the firm made illegal payments to secure prescriptions for drugs reimbursed…
PTAB Declares St. Regis Tribe’s Restasis Patent Rights ‘Illusory’
In another blow to Allergan’s efforts to retain exclusivity for its dry-eye drug Restasis, the U.S. Patent Trials and Appeals Board said Allergan’s transfer of the patents to the St.…
Gottlieb Unveils Pilot for More Efficient Orphan Designation Requests
The FDA plans to launch a new pilot program to improve the efficiency of orphan designation submissions and reviews, Commissioner Scott Gottlieb announced Monday. Source: Drug Industry Daily
- Go to the previous page
- 1
- …
- 156
- 157
- 158
- 159
- 160
- 161
- 162
- …
- 610
- Go to the next page